TY - JOUR
T1 - Changes in depressive symptoms among family caregivers of patients with cancer after bereavement and their association with resilience
T2 - A prospective cohort study
AU - Shimizu, Yoichi
AU - Hayashi, Akitoshi
AU - Maeda, Isseki
AU - Miura, Tomofumi
AU - Inoue, Akira
AU - Takano, Mayuko
AU - Aoyama, Maho
AU - Matsuoka, Yutaka J.
AU - Morita, Tatsuya
AU - Kizawa, Yoshiyuki
AU - Tsuneto, Satoru
AU - Shima, Yasuo
AU - Masukawa, Kento
AU - Miyashita, Mitsunori
N1 - Funding Information:
We are grateful to the HPCJ and all family caregivers and institutions that participated in this study. We also thank Dr. Yosuke Uchitomi (National Cancer Center Hospital Japan), Dr. Masanori Mori (Seirei Mikatahara General Hospital), Dr. Yosuke Matsuda (St. Luke's International Hospital), Associate Prof. Kazuki Sato (Nagoya University Graduate School of Medicine) and Ms. Kazumi Ishigaki (Gratia Hospital) for supporting us in conducting our research. This study was funded by the Grant for Research Advancement on Palliative Medicine, Japanese Society for Palliative Medicine and co-funded by JSPS KAKENHI Grant Numbers 17K17460 (Grant-in-Aid for Young Scientists [B]). The post-loss survey was conducted as part of a nation-wide bereavement surveillance funded by the Japan Hospice Palliative Care Foundation. The authors would like to thank Enago (www.enago.jp) for the English language review.
Funding Information:
We are grateful to the HPCJ and all family caregivers and institutions that participated in this study. We also thank Dr. Yosuke Uchitomi (National Cancer Center Hospital Japan), Dr. Masanori Mori (Seirei Mikatahara General Hospital), Dr. Yosuke Matsuda (St. Luke's International Hospital), Associate Prof. Kazuki Sato (Nagoya University Graduate School of Medicine) and Ms. Kazumi Ishigaki (Gratia Hospital) for supporting us in conducting our research. This study was funded by the Grant for Research Advancement on Palliative Medicine, Japanese Society for Palliative Medicine and co‐funded by JSPS KAKENHI Grant Numbers 17K17460 (Grant‐in‐Aid for Young Scientists [B]). The post‐loss survey was conducted as part of a nation‐wide bereavement surveillance funded by the Japan Hospice Palliative Care Foundation. The authors would like to thank Enago ( www.enago.jp ) for the English language review.
Publisher Copyright:
© 2021 The Authors. Psycho-Oncology published by John Wiley & Sons Ltd.
PY - 2022/1
Y1 - 2022/1
N2 - Objectives: To elucidate changes in depressive symptoms after bereavement and the impact of pre-loss resilience on such changes and on the extent of complicated grief and posttraumatic growth. Methods: Prospective cohort surveys were provided to family caregivers of patients with cancer in four palliative care units (PCUs) before and after bereavement. Pre-loss Connor–Davidson Resilience Scale scores, pre- and post-loss Patient Health Questionnaire-9 scores, post-loss Brief Grief Questionnaire scores, and the expanded Posttraumatic Growth Inventory scores were determined. Results: Out of 186 bereaved family caregivers, 71 (38.2%) responses were analyzed, among which 47% pre-loss and 15% post-loss responses suggested to be a high risk for major depressive disorder (MDD). Approximately 90% of family caregivers at a high risk for post-loss MDD were already at a high risk for pre-loss MDD. Even after adjustment of the background variables as covariates, the interaction effect between family caregivers' pre-loss depressive symptoms and resilience on post-loss depressive symptoms was observed (F = 7.29; p < 0.01). Moreover, pre-loss resilience was not associated with other bereavement outcome measures. Conclusions: Among family caregivers of patients with cancer in PCUs, 47% and 15% had high risk for MDD before and after bereavement, respectively. Moreover, pre-loss resilience mitigated post-loss depressive symptoms among family caregivers who had high risk for MDD before bereavement. However, considering the study's small sample size, further research is needed.
AB - Objectives: To elucidate changes in depressive symptoms after bereavement and the impact of pre-loss resilience on such changes and on the extent of complicated grief and posttraumatic growth. Methods: Prospective cohort surveys were provided to family caregivers of patients with cancer in four palliative care units (PCUs) before and after bereavement. Pre-loss Connor–Davidson Resilience Scale scores, pre- and post-loss Patient Health Questionnaire-9 scores, post-loss Brief Grief Questionnaire scores, and the expanded Posttraumatic Growth Inventory scores were determined. Results: Out of 186 bereaved family caregivers, 71 (38.2%) responses were analyzed, among which 47% pre-loss and 15% post-loss responses suggested to be a high risk for major depressive disorder (MDD). Approximately 90% of family caregivers at a high risk for post-loss MDD were already at a high risk for pre-loss MDD. Even after adjustment of the background variables as covariates, the interaction effect between family caregivers' pre-loss depressive symptoms and resilience on post-loss depressive symptoms was observed (F = 7.29; p < 0.01). Moreover, pre-loss resilience was not associated with other bereavement outcome measures. Conclusions: Among family caregivers of patients with cancer in PCUs, 47% and 15% had high risk for MDD before and after bereavement, respectively. Moreover, pre-loss resilience mitigated post-loss depressive symptoms among family caregivers who had high risk for MDD before bereavement. However, considering the study's small sample size, further research is needed.
UR - http://www.scopus.com/inward/record.url?scp=85112619475&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112619475&partnerID=8YFLogxK
U2 - 10.1002/pon.5783
DO - 10.1002/pon.5783
M3 - Article
C2 - 34343380
AN - SCOPUS:85112619475
SN - 1057-9249
VL - 31
SP - 86
EP - 97
JO - Psycho-Oncology
JF - Psycho-Oncology
IS - 1
ER -